Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Innocoll clinical trials
Part of Gurnet Point L.P., which holds 100% as of 2017-07-24. Source
The registry lists 21 studies whose lead sponsor is Innocoll. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 13, 2023.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Innocoll.
- Innocoll21 studiesSame company
Something wrong?
Focus areas
Conditions Innocoll leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 21 of 21.
- An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue SurgeriesCompletedNCT04785638Phase 3
- Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in AbdominoplastyCompletedNCT04785625Phase 3
- Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot UlcerCompletedNCT00593567Phase 2
- Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound InfectionCompletedNCT00600483Phase 3
- The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot UlcersCompletedNCT00659646Phase 2
- Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot UlcersCompletedNCT02447172Phase 3
- A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound InfectionCompletedNCT00600925Phase 3
- Usability of the CollaGUARD Adhesion Barrier Following Hysteroscopic AdhesiolysisCompletedNCT02348541Not applicable
- Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot UlcersCompletedNCT02427802Phase 3
- Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open HernioplastyCompletedNCT03234374Phase 1
- Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia RepairStatus unknownNCT03262688Phase 3
- Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal HysterectomyCompletedNCT00624910Phase 2
- Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy HerniorrhaphyCompletedNCT01220024Phase 2
- Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh HerniorrhaphyCompletedNCT00626886Phase 2
- Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After HernioplastyCompletedNCT02523599Phase 3
- Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After HernioplastyCompletedNCT02525133Phase 3
- Efficacy and Safety of the CollaRx Bupivacaine Implant Compared to the ON-Q Painbuster Following Abdominal HysterectomyCompletedNCT00749749Phase 2
- Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical HerniorrhaphyCompletedNCT01224145Phase 2
- Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal SurgeryTerminatedNCT00661466Phase 2
- Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll ImplantCompletedNCT02232178Phase 2
- Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot UlcerTerminatedNCT00658957Phase 2